Literature DB >> 22194366

3D computerized occlusion rating of embolized experimental aneurysms using noninvasive 1.5T MR imaging.

C Sherif1, S Marbacher, J Fandino, S Erhardt, V Neuschmelting, M Killer, G Mach, L Remonda.   

Abstract

BACKGROUND AND
PURPOSE: For embolized cerebral aneurysms, the initial occlusion rate is the most powerful parameter to predict aneurysm rerupture and recanalization. However, the occlusion rate is only estimated subjectively in clinical routine. To minimize subjective bias, computer occlusion-rating (COR) was successfully validated for 2D images. To minimize the remaining inaccuracy of 2D-COR, COR was applied to 1.5T 3D MR imaging.
MATERIALS AND METHODS: Twelve experimental rabbit aneurysms were subjected to stent-assisted coil embolization followed by 2D DSA and 3D MR imaging. Subjective occlusion-rate (SOR) was estimated. Linear parameters (aneurysm length, neck width, parent vessel diameter) were measured on 2D DSA and 3D MR imaging. The occlusion rate was measured by contrast medium-based identification of the nonoccluded 2D area/3D volume in relation to the total aneurysm 2D area/3D volume. 2D and 3D parameters were statistically compared.
RESULTS: There were no limiting metallic artifacts by using 3D MR imaging. Linear parameters (millimeters) were nearly identical on 2D DSA and 3D MR imaging (aneurysm length: 7.5 ± 2.6 versus 7.4 ± 2.5, P = .2334; neck width: 3.8 ± 1.0 versus 3.7 ± 1.1, P = .6377; parent vessel diameter: 2.7 ± 0.6 versus 2.7 ± 0.5, P = .8438), proving the high accuracy of 3D MR imaging. COR measured on 3D MR imaging was considerably lower (61.8% ± 26.6%) compared with the following: 1) 2D-COR (65.6% ± 27.1%, P = .0537) and 2) 2D-SOR estimations (69.2% ± 27.4%, P = .002). These findings demonstrate unacceptable bias in the current clinical standard SOR estimations.
CONCLUSIONS: 3D-COR of embolized aneurysms is easily feasible. Its accuracy is superior to that of the clinical standard 2D-SOR. The difference between 3D-COR and 2D-COR approached statistical significance. 3D-COR may add objectivity to the ability to stratify the risk of rerupture in embolized cerebral aneurysms.

Entities:  

Mesh:

Year:  2011        PMID: 22194366      PMCID: PMC8050454          DOI: 10.3174/ajnr.A2843

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  21 in total

1.  A compartmentalized volumetric system for outcome analysis of coiled cerebral aneurysms: aneurysm-coil mass-neck outcome assessment system.

Authors:  Simon C H Yu; Wai King So; Albert Chi Shing Chung; Kwok Tung Lee; George Kwok Chu Wong
Journal:  Neurosurgery       Date:  2009-01       Impact factor: 4.654

2.  Evaluation of cerebral aneurysms with high-resolution MR angiography using a section-interpolation technique: correlation with digital subtraction angiography.

Authors:  T S Chung; J Y Joo; S K Lee; D Chien; G Laub
Journal:  AJNR Am J Neuroradiol       Date:  1999-02       Impact factor: 3.825

3.  Complex bilobular, bisaccular, and broad-neck microsurgical aneurysm formation in the rabbit bifurcation model for the study of upcoming endovascular techniques.

Authors:  S Marbacher; S Erhardt; J-A Schläppi; D Coluccia; L Remonda; J Fandino; C Sherif
Journal:  AJNR Am J Neuroradiol       Date:  2011-02-10       Impact factor: 3.825

4.  Endovascular treatment of unruptured aneurysms.

Authors:  D Roy; G Milot; J Raymond
Journal:  Stroke       Date:  2001-09       Impact factor: 7.914

5.  Improved microsurgical creation of venous pouch arterial bifurcation aneurysms in rabbits.

Authors:  C Sherif; S Marbacher; S Erhardt; J Fandino
Journal:  AJNR Am J Neuroradiol       Date:  2010-10-21       Impact factor: 3.825

6.  High-resolution three-dimensional 3 T magnetic resonance angiography for the evaluation of experimental aneurysm in the rabbit.

Authors:  Camillo Sherif; Serge Marbacher; Javier Fandino
Journal:  Neurol Res       Date:  2009-02-12       Impact factor: 2.448

7.  Three-dimensional time-of-flight MR angiography at 3 T compared to digital subtraction angiography in the follow-up of ruptured and coiled intracranial aneurysms: a prospective study.

Authors:  H Urbach; U Dorenbeck; M von Falkenhausen; K Wilhelm; W Willinek; C Schaller; S Flacke
Journal:  Neuroradiology       Date:  2008-05       Impact factor: 2.804

8.  Computer-assisted quantification of occlusion and coil densities on angiographic and histological images of experimental aneurysms.

Authors:  Camillo Sherif; Hanns Plenk; Karl Grossschmidt; Fabian Kanz; Gerhard Bavinzski
Journal:  Neurosurgery       Date:  2006-03       Impact factor: 4.654

9.  Predictors of rehemorrhage after treatment of ruptured intracranial aneurysms: the Cerebral Aneurysm Rerupture After Treatment (CARAT) study.

Authors:  S Claiborne Johnston; Christopher F Dowd; Randall T Higashida; Michael T Lawton; Gary R Duckwiler; Daryl R Gress
Journal:  Stroke       Date:  2007-11-29       Impact factor: 7.914

10.  International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion.

Authors:  Andrew J Molyneux; Richard S C Kerr; Ly-Mee Yu; Mike Clarke; Mary Sneade; Julia A Yarnold; Peter Sandercock
Journal:  Lancet       Date:  2005 Sep 3-9       Impact factor: 79.321

View more
  2 in total

1.  Computerized occlusion rating: a superior predictor of aneurysm rebleeding for ruptured embolized aneurysms.

Authors:  C Sherif; A Gruber; E Schuster; E Lahnsteiner; D Gibson; H Milavec; B Feichter; M Wiesender; C Dorfer; M Krawagna; A Di Ieva; G Bavinszki; E Knosp
Journal:  AJNR Am J Neuroradiol       Date:  2012-04-12       Impact factor: 3.825

2.  Computerized Angiographic Occlusion Rating for Ruptured Clipped Aneurysms is Superior to Subjective Occlusion Rating.

Authors:  A R Al-Schameri; G Baltsavias; P Winkler; M Lunzer; M Kral; L Machegger; F Weymayr; S Emich; C Sherif; B Richling
Journal:  AJNR Am J Neuroradiol       Date:  2015-07-30       Impact factor: 3.825

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.